2025-04-24T01:48:21+03:00[Europe/Moscow] en true <p>Infliximab, Certolizumab, Adalimumab, Golimumab</p>, <p>Remicade </p>, <p>Humira</p>, <p>Cimzia </p>, <p>Simponi </p>, <p>a</p>, <p>d</p>, <p>e</p>, <p>Tysabri </p>, <p>moderate-severe UC who failed: immunomodulators, anti-TNFa</p>, <p>Stelara </p>, <p>f</p>, <p>Entyvio </p>, <p>c</p>, <p>infliximab, vedolizumab, ustekinumab </p>, <p>adalimumab, golimumab </p>, <p>f</p>, <p>a</p>, <p>b,d</p>, <p>serious infections, cancer, CV events </p>, <p>Xeljanz </p>, <p>Rinvoq </p>, <p>mesalamine</p>, <p>Anti-TNFa, thiopurine, cyclosporine, Ustekinumab, JAKs</p>, <p>Vedolizumab </p>, <p>mesalamine +/- steroid, Anti-TNF, ustekinumab, Tofacitinib, Vedolizumab, IV cyclosporine </p>, <p>arthralgia, nasopharyngitis, HA/fatigue</p>, <p>TNFa, JAK, Natalizumab </p>, <p>d</p> flashcards
Ulcerative Colitis (Biologics)

Ulcerative Colitis (Biologics)

Customize
collection saved
Share
Long Term Learning Spaced Repetition
Add to Long Term Learning Desk
Fast learning Repeat this set of flashcards
Preview Test Spell
Play
Match
Review

  • Infliximab, Certolizumab, Adalimumab, Golimumab

    What are the TNFa inhibitors? (4)

  • Remicade

    Infliximab =

  • Humira

    Adalimumab =

  • Cimzia

    Certolizumab =

  • Simponi

    Golimumab =

  • a

    What is the preferred treatment for moderate-severe UC?

    a) Anti-TNFa

    b) Ustekinumab

    c) Mirikizumab

    d) JAK inhibitors

    e) Natalizumab

    f) Vedolizumab

  • d

    Which agent has a BBW for serious infections?

    a) Anti-TNFa

    b) Ustekinumab

    c) Mirikizumab

    d) JAK inhibitors

    e) Natalizumab

    f) Vedolizumab

  • e

    Which has a REMS program for PML?

    a) Anti-TNFa

    b) Ustekinumab

    c) Mirikizumab

    d) JAK inhibitors

    e) Natalizumab

    f) Vedolizumab

  • Tysabri

    Natalizumab =

  • moderate-severe UC who failed: immunomodulators, anti-TNFa

    What is the indication for Ustekinumab? (3)

  • Stelara

    Ustekinumab =

  • f

    Which is indicated ONLY for refractory disease?

    a) Anti-TNFa

    b) Ustekinumab

    c) Mirikizumab

    d) JAK inhibitors

    e) Natalizumab

    f) Vedolizumab

  • Entyvio

    Vedolizumab =

  • c

    Which TNFas is the ONLY one available via IV?

    a) Adalimumab

    b) Golimumab

    c) Infliximab

    d) Certolizumab

  • infliximab, vedolizumab, ustekinumab

    Which biologics are available via IV? (3)

  • adalimumab, golimumab

    Which biologics are available in pre-filled pens? (2)

  • f

    Which can cause nasopharyngitis?

    a) Anti-TNFa

    b) Ustekinumab

    c) Mirikizumab

    d) JAK inhibitors

    e) Natalizumab

    f) Vedolizumab

  • a

    Which is administered every 2 weeks?

    a) Adalimumab

    b) Golimumab

    c) Infliximab

    d) Certolizumab

  • b,d

    Which is administered every 4 weeks?

    a) Adalimumab

    b) Golimumab

    c) Infliximab

    d) Certolizumab

  • serious infections, cancer, CV events

    What are the BWs for JAK inhibitors? (3)

  • Xeljanz

    Tofacitinib =

  • Rinvoq

    Upadacitinib =

  • mesalamine

    Which drugs are considered maintenance medication for Mild disease?

  • Anti-TNFa, thiopurine, cyclosporine, Ustekinumab, JAKs

    Which drugs are considered maintenance medication for Moderate-Severe Disease? (5)

  • Vedolizumab

    Which drug is for Refractory disease?

  • mesalamine +/- steroid, Anti-TNF, ustekinumab, Tofacitinib, Vedolizumab, IV cyclosporine

    Which drugs can induce remission? (6)

  • arthralgia, nasopharyngitis, HA/fatigue

    Vedolizumab AE's? (3)

  • TNFa, JAK, Natalizumab

    Which immunomodulators have a BW? (3)

  • d

    Which has a REMS program for CV events?

    a) Anti-TNFa

    b) Ustekinumab

    c) Mirikizumab

    d) JAK inhibitors

    e) Natalizumab

    f) Vedolizumab